Skip to main content
Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
29.50
+0.60 (2.08%)
Dec 20, 2024, 4:00 PM EST - Market closed

Baxter International Revenue

Baxter International had revenue of $2.70B in the quarter ending September 30, 2024, with 3.85% growth. This brings the company's revenue in the last twelve months to $15.06B, up 32.37% year-over-year. In the year 2023, Baxter International had annual revenue of $14.81B with 2.12% growth.

Revenue (ttm)
$15.06B
Revenue Growth
+32.37%
P/S Ratio
1.00
Revenue / Employee
$251,033
Employees
60,000
Market Cap
15.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.81B307.00M2.12%
Dec 31, 202214.51B2.36B19.43%
Dec 31, 202112.15B473.00M4.05%
Dec 31, 202011.67B311.00M2.74%
Dec 31, 201911.36B263.00M2.37%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molina Healthcare 37.54B
Viatris 15.05B
Avantor 6.82B
Moderna 5.08B
Hologic 4.03B
Align Technology 3.96B
United Therapeutics 2.76B
Royalty Pharma 2.27B
Revenue Rankings

BAX News

More News